Corbus Pharmaceuticals is focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its industry leading pipeline of endocannabinoid system-targeting drug candidates. We understand the importance of collaborations in our industry and our Business Development team is always focused on potential new opportunities.

Our approach to partnering leverages our extensive experience in developing clinical phase assets while creating substantial value for our partners and patients. We welcome interest from parties developing clinical or pre-clinical therapies to treat inflammatory and fibrotic diseases to discuss the potential for licensing or collaboration.

We look forward to hearing from you, please complete this form to contact us.